What is the first-line treatment for chronic kidney disease (CKD)?

The first-line treatment for chronic kidney disease (CKD) is the management of underlying causes, such as hypertension and diabetes. This approach is crucial because CKD often develops as a complication of these chronic conditions. By effectively managing hypertension and maintaining optimal blood glucose levels in diabetic patients, healthcare providers can slow the progression of kidney damage and preserve kidney function.

Controlling blood pressure, particularly through the use of medications like ACE inhibitors or ARBs, has been shown to have renal protective effects. Additionally, tight glycemic control in patients with diabetes can significantly reduce the risk of developing complications associated with CKD. This proactive management strategy helps in maintaining kidney health and delaying the need for more invasive treatments such as dialysis or transplantation.

Dialysis initiation and kidney transplantation are more advanced treatment options typically considered only when CKD has progressed to end-stage renal disease (ESRD). Potassium supplements are generally not a treatment for CKD; in fact, they may pose risks, as patients with CKD are often at risk for hyperkalemia due to impaired kidney function.